Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: onr:"swepub:oai:DiVA.org:oru-83754" > Neurobehavioral def...

1 av 1
Föregående post
Nästa post
Till träfflistan

Bellanger, MartineEHESP School of Public Health, Paris, France (författare)

Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union

Artikel/kapitelEngelska2015

Förlag, utgivningsår, omfång ...

Oxford University Press,2015
printrdacarrier

Nummerbeteckningar

LIBRIS-ID:oai:DiVA.org:oru-83754
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-83754URI
https://doi.org/10.1210/jc.2014-4323DOI

Kompletterande språkuppgifter

Språk:engelska
Sammanfattning på:engelska

Ingår i deldatabas

SwePubSwePub

Klassifikation

Ämneskategori:ref swepub-contenttype
Ämneskategori:art swepub-publicationtype

Anmärkningar

Funding Agency:Endocrine Society John Merck Fund Broad Reach Foundation Oak Foundation
CONTEXT: Epidemiological studies and animal models demonstrate that endocrine-disrupting chemicals (EDCs) contribute to cognitive deficits and neurodevelopmental disabilities.OBJECTIVE: The objective was to estimate neurodevelopmental disability and associated costs that can be reasonably attributed to EDC exposure in the European Union.DESIGN: An expert panel applied a weight-of-evidence characterization adapted from the Intergovernmental Panel on Climate Change. Exposure-response relationships and reference levels were evaluated for relevant EDCs, and biomarker data were organized from peer-reviewed studies to represent European exposure and approximate burden of disease. Cost estimation as of 2010 utilized lifetime economic productivity estimates, lifetime cost estimates for autism spectrum disorder, and annual costs for attention-deficit hyperactivity disorder. Setting, Patients and Participants, and Intervention: Cost estimation was carried out from a societal perspective, ie, including direct costs (eg, treatment costs) and indirect costs such as productivity loss.RESULTS: The panel identified a 70-100% probability that polybrominated diphenyl ether and organophosphate exposures contribute to IQ loss in the European population. Polybrominated diphenyl ether exposures were associated with 873,000 (sensitivity analysis, 148,000 to 2.02 million) lost IQ points and 3290 (sensitivity analysis, 3290 to 8080) cases of intellectual disability, at costs of €9.59 billion (sensitivity analysis, €1.58 billion to €22.4 billion). Organophosphate exposures were associated with 13.0 million (sensitivity analysis, 4.24 million to 17.1 million) lost IQ points and 59 300 (sensitivity analysis, 16,500 to 84,400) cases of intellectual disability, at costs of €146 billion (sensitivity analysis, €46.8 billion to €194 billion). Autism spectrum disorder causation by multiple EDCs was assigned a 20-39% probability, with 316 (sensitivity analysis, 126-631) attributable cases at a cost of €199 million (sensitivity analysis, €79.7 million to €399 million). Attention-deficit hyperactivity disorder causation by multiple EDCs was assigned a 20-69% probability, with 19 300 to 31 200 attributable cases at a cost of €1.21 billion to €2.86 billion.CONCLUSIONS: EDC exposures in Europe contribute substantially to neurobehavioral deficits and disease, with a high probability of >€150 billion costs/year. These results emphasize the advantages of controlling EDC exposure.

Ämnesord och genrebeteckningar

MEDICIN OCH HÄLSOVETENSKAP Hälsovetenskap Arbetsmedicin och miljömedicin hsv//swe
MEDICAL AND HEALTH SCIENCES Health Sciences Occupational Health and Environmental Health hsv//eng
Enviromental Science
Miljövetenskap

Biuppslag (personer, institutioner, konferenser, titlar ...)

Demeneix, BarbaraUnité Mixte de Recherche, Muséum National d'Histoire Naturelle, Paris, France (författare)
Grandjean, PhilippeHarvard School of Public Health, Boston, USA; University of Southern Denmark, Odense, Denmark (författare)
Zoeller, R. Thomas,1952-University of Massachusetts, Amherst, USA(Swepub:oru)tzr (författare)
Trasande, LeonardoDepartment of Pediatrics, NYU, New York, USA; Wagner School of Public Service, New York, USA; Department of Nutrition, Food and Public Health, Steinhardt School of Culture, Education, and Human Development, New York, USA; Global Institute of Public Health, New York, USA (författare)
EHESP School of Public Health, Paris, FranceUnité Mixte de Recherche, Muséum National d'Histoire Naturelle, Paris, France (creator_code:org_t)

Sammanhörande titlar

Ingår i:Journal of Clinical Endocrinology and Metabolism: Oxford University Press100:4, s. 1256-12660021-972X1945-7197

Internetlänk

Hitta via bibliotek

Journal of Clinical Endocrinology and Metabolism (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

1 av 1
Föregående post
Nästa post
Till träfflistan

Hitta mer i SwePub

Av författaren/redakt...: Bellanger, Marti ...; Demeneix, Barbar ...; Grandjean, Phili ...; Zoeller, R. Thom ...; Trasande, Leonar ...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Hälsovetenskap; och Arbetsmedicin oc ...

Artiklar i publikationen: Journal of Clini ...

Av lärosätet: Örebro universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se